<DOC>
	<DOC>NCT01429064</DOC>
	<brief_summary>The purpose of this study is to evaluate safety and tolerability of ODM-201 in patients with castrate resistant prostate cancer.</brief_summary>
	<brief_title>Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Written informed consent Successful completion of study protocol 3104001 Response or stable disease in study 3104001 at week 12 New serious concurrent medical condition Not able to swallow the study drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>